Back to Search
Start Over
Identification and validation of tryptophan-related gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma reveals a critical role for PTTG1.
- Source :
-
Frontiers in immunology [Front Immunol] 2024 Jul 31; Vol. 15, pp. 1386427. Date of Electronic Publication: 2024 Jul 31 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Introduction: Tryptophan metabolism is strongly associated with immunosuppression and may influence lung adenocarcinoma prognosis as well as tumor microenvironment alterations.<br />Methods: Sequencing datasets were obtained from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) database. Two different clusters were identified by consensus clustering, and prognostic models were established based on differentially expressed genes (DEGs) in the two clusters. We investigated differences in mutational landscapes, enrichment pathways, immune cell infiltration, and immunotherapy between high- and low-risk scoring groups. Single-cell sequencing data from Bischoff et al. were used to identify and quantify tryptophan metabolism, and model genes were comprehensively analyzed. Finally, PTTG1 was analyzed at the pan-cancer level by the pan-TCGA cohort.<br />Results: Risk score was defined as an independent prognostic factor for lung adenocarcinoma and was effective in predicting immunotherapy response in patients with lung adenocarcinoma. PTTG1 is one of the key genes, and knockdown of PTTG1 in vitro decreases lung adenocarcinoma cell proliferation and migration and promotes apoptosis and down-regulation of tryptophan metabolism regulators in lung adenocarcinoma cells.<br />Discussion: Our study revealed the pattern and molecular features of tryptophan metabolism in lung adenocarcinoma patients, established a model of tryptophan metabolism-associated lung adenocarcinoma prognosis, and explored the roles of PTTG1 in lung adenocarcinoma progression, EMT process, and tryptophan metabolism.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Wang, Zhang, Zuo, Chen, Wang, Xie, Ma, Min, Wang and Lian.)
- Subjects :
- Humans
Prognosis
Gene Expression Regulation, Neoplastic
Female
Male
Biomarkers, Tumor genetics
Cell Line, Tumor
Transcriptome
Middle Aged
Gene Expression Profiling
Tumor Microenvironment immunology
Tumor Microenvironment genetics
Tryptophan metabolism
Adenocarcinoma of Lung genetics
Adenocarcinoma of Lung immunology
Adenocarcinoma of Lung mortality
Lung Neoplasms genetics
Lung Neoplasms immunology
Lung Neoplasms mortality
Lung Neoplasms therapy
Immunotherapy methods
Subjects
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 15
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 39144144
- Full Text :
- https://doi.org/10.3389/fimmu.2024.1386427